ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,245
-0,76%
Bitcoin
56 921,70
-6,07%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Precipio Inc (PRPO)

  7. Precipio Inc (PRPO) Actualités

PRPO Precipio Inc

5,7499
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:09:35
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Precipio Inc PRPO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 5,7499 10:09:35
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,7499
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/3/202422:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
13/2/202416:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
06/2/202416:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
23/1/202416:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
19/1/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202416:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
04/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202423:01EDGAR2Form 8-K - Current report
02/1/202415:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
14/12/202323:00EDGAR2Form 8-K - Current report
14/12/202322:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
16/11/202323:15EDGAR2Form 8-K - Current report
16/11/202323:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
13/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202321:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202315:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
06/10/202322:34EDGAR2Form 8-K - Current report
03/10/202316:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
28/9/202315:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
25/9/202317:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
21/9/202323:10EDGAR2Form 8-K - Current report
14/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
14/8/202322:00EDGAR2Form 8-K - Current report
11/8/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202323:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
08/8/202315:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
03/8/202315:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
01/8/202315:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
07/7/202322:30EDGAR2Form S-1 - General form for registration of securities under..
14/6/202315:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
13/6/202315:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
08/6/202314:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
07/6/202315:30GLOBEProjected cash burn reduced by $1.5 million annually from..
22/5/202317:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
17/5/202322:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
15/5/202322:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
04/5/202319:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
04/5/202316:00GLOBEPrecipio Signs Another HemeScreen™ Customer

Dernières Valeurs Consultées

NASDAQ
PRPO
Precipio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés